HEALTH, WEALTH AND THE FUTURE OF HEALTHTECH

Updated: 1 hour ago

One of the themes I keep returning to in my own life and work is the connection between health and wealth.
Not wealth simply as money.
But wealth as energy, time, freedom, relationships, purpose, knowledge and the ability to create a positive impact.
That is also why I find healthtech so interesting.

At the London Healthtech Roundtable, hosted by the London Venture Capital Network, the discussion focused on a practical challenge:
How do we move from promising NHS pilots to scalable, sustainable businesses?
But for me, the conversation went deeper.
It touched on something I believe strongly:
Innovation only truly matters when it improves people's lives.
A brilliant technology sitting in a laboratory is potential. A successful pilot is proof. But real impact comes when that innovation reaches thousands, perhaps millions, of people.
That is where capital, healthcare and purpose need to come together.
From innovation to impact
One of the strongest messages from the afternoon was the importance of decision-grade evidence.
Not simply data that is interesting.
Evidence that changes a decision.
An investor says yes.
A hospital adopts the technology.
A clinician changes the way they treat a patient.
A healthcare system allocates a budget.
That is the point where innovation begins to move into the real world.
One case study involved an AI cancer-detection company that spent around 18 months quietly building evidence before making much noise about what it was doing.
The company subsequently reached approximately £1.2 million ARR from the NHS, became profitable within 18 months and used that credibility as a platform for expansion into the United States.
I liked that example because it reflects something I increasingly believe:
Build substance before visibility.
We live in a world where it is easy to talk about what we are building. The harder work is actually building it.
The NHS as a global launchpad
The NHS has its challenges, particularly around procurement and speed of adoption.
But it also has enormous global credibility.
If a healthcare company can demonstrate clinical and economic value within the NHS, that validation can become incredibly powerful internationally.
One comment during the discussion captured the commercial opportunity:
“If you can sell to the NHS, add a zero for US pricing”
The phrase may be deliberately provocative, but the underlying idea is important.
The UK can become the place where companies prove their technology.
The global market can then become the place where they scale it.
I would love to see more companies follow that model:
Build in Britain. Validate through the NHS. Scale globally. Keep the talent, intellectual property and economic value anchored here.

Health and wealth are connected
My own journey has changed the way I think about health.
There are moments in life when you realise very clearly that health is not simply another sector of the economy.
It is the foundation on which almost everything else sits.
Without health, our relationship with time changes.
Our relationship with money changes.
Our relationship with ambition changes.
Our understanding of what really matters changes.
This is part of the thinking behind my broader Health & Wealth philosophy.
The two are not separate.
A healthy society is ultimately a more productive, creative and prosperous society.
And intelligent capital directed towards preventative healthcare, diagnostics, longevity, medical technology and better patient outcomes can create both financial returns and profound human value.
That is the type of intersection I find increasingly compelling.
Capital should do more than fund
I spend a significant amount of my time connecting founders, investors, family offices and opportunities.
And one lesson becomes clearer the more businesses I see:
Capital should not simply keep a company alive. The right capital should accelerate its purpose.
For a healthtech business, that might mean funding clinical validation.
Opening the right international market.
Connecting the founder with a healthcare system.
Helping build the commercial team.
Or giving the business enough runway to reach the point where the economics finally work.
The wrong investor can push a company toward short-term decisions.
The right investor can help create something that lasts.
That is why I increasingly think about intelligent capital rather than simply capital.
Money plus knowledge.
Money plus networks.
Money plus patience.
Money plus purpose.

Shine Your Light
This also connects with a philosophy I have been developing through Shine Your Light.
I believe everyone has something unique they can contribute.
A scientist may develop a breakthrough diagnostic.
A doctor may see a problem nobody else has noticed.
An entrepreneur may find a way to scale the solution.
An investor may provide the capital.
A connector may bring the right people into the same room.
No single person necessarily creates the impact.
The impact often happens when the right people shine their light together.
That is why ecosystems matter so much.
Healthcare cannot be transformed by founders alone.
It requires scientists, clinicians, entrepreneurs, investors, policymakers, healthcare systems and communities working together.
When those pieces align, capital becomes more than money.
Technology becomes more than innovation.
Business becomes more than profit.
It becomes a mechanism for improving human life. And perhaps that is one of the most interesting forms of wealth we can create.
Better health. More time. Greater freedom. More opportunity. And a positive impact that extends beyond ourselves.
That is where Health & Wealth begins to mean something much bigger.
DM to discuss funding, innovation and more

#HealthAndWealth #ShineYourLight #HealthTech #HealthcareInnovation #NHS #DigitalHealth #ImpactInvesting #VentureCapital #AI #LifeSciences #PurposeDrivenBusiness #UKInnovation



Comments